Synthesis of [18F]phencyclidines for glutamate receptor mapping
β Scribed by M.E. Van Dort; D.J. Yang; M.R. Kilbourn; D.J. Gole; A. Kalir; E.F. Domino; A.B. Young; D.M. Wieland
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 87 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
L-Glutamate is a major excitatory neurotransmitter in the mammalian brain. Excessive stimulation of excitatory amino acid receptors has been implicated in neurodegenerative disorders such as Alzheimers disease (1); hypofunction of the glutamate system may be involved in schizophrenic-like disorders (2). Three distinct pharmacological classes of glutamate receptors have been identified which reflect the actions of the relatively selective agonists kainate, quisqualate and N-methyl-D-aspartate (NMDA).
Recent findings (3) suggest that drugs such as phencyclidine (PCP) and the PCP analog TCP bind either to an allosteric NMDA site or possibly t o the open channel itself. These findings have created a renewed interest developing a radiolabeled PCP-like compound for mapping NMDA-linked glutamate receptors in the mammalian brain by PET.
π SIMILAR VOLUMES
## Abstract The palladiumβmediated __N__βarylation of indoles with 4β[^18^F]fluoroiodobenzene as a novel radiolabelling method has been developed. Optimized reaction conditions were elaborated by variation of different catalyst systems (CuI/1,2βdiamines and Pd~2~(dba)~3~/phosphine ligands), bases a
Glutamate receptors (GluRs) mediate excitatory neurotransmission and may have important roles in central nervous system disorders. To characterize the human GLUR5 gene, which is located on human chromosome 21q22.1, we isolated cDNAs, genomic phage lambda clones, and yeast artificial chromosomes (YAC